Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study. - Schmidli, H.; Peng, B.; Riviere, G-J.; Capdeville, R.; Hensley, M.; Gathmann, I.; Bolton, A. E.; Racine-Poon, A. (British Journal of Clinical Pharmacology, 2005)